Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma

British Journal of Haematology

Volumn 137, Issue 2, 2007, Pages 133-141

  Au, Gough G ^a   Lincz, Lisa F ^b   Enno, Arno ^b   Shafren, Darren R ^a,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c Viralytics Ltd   (Australia)

Author keywords

Coxsackievirus A21; Multiple myeloma; Oncolytic virotherapy

Indexed keywords

DECAY ACCELERATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; ONCOLYTIC COXSACKIEVIRUS A21; ONCOLYTIC VIRUS; SYNDECAN 1; UNCLASSIFIED DRUG;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL; BONE MARROW BIOPSY; CANCER CELL CULTURE; CELL ASSAY; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONTROLLED STUDY; COXSACKIE VIRUS A; CYTOLYSIS; DATA ANALYSIS; DRUG PENETRATION; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; DRUG SPECIFICITY; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOMA CELL; ONCOLYTIC VIROTHERAPY; PLASMA CELL; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROVOCATION TEST; STEM CELL; VIRUS REPLICATION;

ANTIGENS, CD55; BONE MARROW CELLS; BONE MARROW PURGING; CELL DEATH; COCULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; ENTEROVIRUS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES, MONONUCLEAR; MULTIPLE MYELOMA; NEOPLASM PROTEINS; ONCOLYTIC VIROTHERAPY; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 33947538023     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06550.x     Document Type: Article

References (31)

1. Alain, T., Hirasawa, K., Pon, K.J., Nishikawa, S.G., Urbanski, S.J., Auer, Y., Luider, J., Martin, A., Johnston, R.N., Janowska-Wieczorek, A., Lee, P.W. & Kossakowska, A.E. (2002) Reovirus therapy of lymphoid malignancies. Blood, 100, 4146-4153.
2. Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., Mayo, J.G., Shoemaker, R.H. & Boyd, M.R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research, 48, 589-601.
3. Anderson, K.C., Kyle, R.A., Berenson, J.R. & Dalton, W.S. (1998) Recent advances in the biology and treatment of multiple myeloma, pp. 63-88. The American Society of Haematology Education Program, Washington, DC.
4. Au, G.G., Lindberg, A.M., Barry, R.D. & Shafren, D.R. (2005) Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21. International Journal of Oncology, 26, 1471-1476.
5. Berendt, A.R., McDowall, A., Craig, A.G., Bates, P.A., Sternberg, M.J.E., Marsh, K., Newbold, C.I. & Hogg, M. (1992) The binding site on ICAM-1 for plasmodium falciparum-infected erythrocytes overlaps, but is distinct from the LFA-1-binding site. Cell, 68, 71-81.
6. Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T.A. & Anderson, K.C. (1996) Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood, 87, 1104-1112.
7. Grote, D., Russell, S.J., Cornu, T.I., Cattaneo, R., Vile, R., Poland, G.A. & Fielding, A.K. (2001) Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood, 97, 3746-3754.
8. Hallek, M., Bergsagel, P.L. & Anderson, K.C. (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood, 91, 3-21.
9. Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., Adams, J. & Anderson, K.C. (2002) NF-kappa B as a therapeutic target in multiple myeloma. Journal of Biological Chemistry, 277, 16639-16647.
10. Huang, Y.W., Richardson, J.A. & Vitetta, E.S. (1995) Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Cancer Research, 55, 610-616.
11. King, A.M.Q., Brown, F., Christian, P., Hovi, T., Hyypiä, T., Knowles, N.J., Lemon, S.M., Minor, P.D., Palmenberg, A.C., Skern, T. & Stanway, G. (2000). Picornaviridae. In: Virus Taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses (ed. by M.H.V. Van Regenmortel, C.M. Fauquet, D.H.L. Bishop, C.H. Calisher, E.B. Carsten, M.K. Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle & R.B. Wickner), pp. 657-673. Academic Press, New York, San Diego.
12. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.F. & Melton, III, L.J., (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 346, 564-569.
13. Landowski, T.H., Olashaw, N.E., Agrawal, D. & Dalton, W.S. (2003) Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells. Oncogene, 22, 2417-2421.
14. Lichty, B.D., Stojdl, D.F., Taylor, R.A., Miller, L., Frenkel, I., Atkins, H. & Bell, J.C. (2004) Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancy. Human Gene therapy, 15, 821-831.
15. Lin, E. & Nemunaitis, J. (2004) Oncolytic viral therapies. Cancer Gene therapy, 11, 643-664.
16. Ni, H., Ergin, M., Huang, Q., Qin, J.Z., Amin, H.M., Martinez, R.L., Saeed, S., Barton, K. & Alkan, S. (2001) Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. British Journal of Haematology, 115, 279-286.
17. Pallansch, M.A. & Roos, R.P. (2001) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields Virology (ed. by D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman & S.E. Straus). pp. 723-776. Lippincott Williams & Wilkins, Philadelphia, PA.
18. Parato, K.A., Senger, D., Forsyth, P.A. & Bell, J.C. (2005) Recent progress in the battle between oncolytic viruses and tumours. Nature Review. Cancer, 5, 965-976.
19. Peng, K.W., Ahmann, G.J., Pham, L., Greipp, P.R., Cattaneo, R. & Russell, S.J. (2001) Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood, 98, 2002-2007.
20. Peng, K.W., Donovan, K.A., Schneider, U., Cattaneo, R., Lust, J.A. & Russell, S.J. (2003) Oncolytic measles viruses displaying a single-chain antibody against CD38,a myeloma cell marker. Blood, 101, 2557-2562.
21. Rogers, J.M., Diana, G.D. & McKinlay, M.A. (1999) Pleconaril. A broad spectrum antipicornaviral agent. Advances in Experimental Medicine and Biology, 458, 69-76.
22. Rotbart, H.A. (1999) Antiviral therapy for enteroviral infections. Pediatric Infectious Disease Journal, 18, 632-633.
23. Rueckert, R.R. (1996). Picornaviridae: the viruses and their replication. In: Fields Virology (ed. by B.N. Fields, D.M. Knipe & P.M. Howley), pp. 609-645. Lippincott-Raven, Philadelphia, PA.
24. Shafren, D.R., Dorahy, D.J., Greive, S.J., Burns, G.F. & Barry, R.D. (1997a) Mouse cells expressing human intercellular adhesion molecule-1 are susceptible to infection by Coxsackievirus A21. Journal of Virology, 71, 785-789.
25. Shafren, D.R., Dorahy, D.J., Ingham, R.A., Burns, G.F. & Barry, R.D. (1997b) Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. Journal of Virology, 71, 4736-4743.
26. Shafren, D.R., Au, G.G., Nguyen, T., Newcombe, N.G., Haley, E.S., Beagley, L., Johansson, E.S., Hersey, P. & Barry, R.D. (2004) Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21. Clinical Cancer Research, 10, 53-60.
27. van de Stolpe, A. & van der Saag, P.T. (1996) Intercellular adhesion molecule-1. Journal of Molecular Medicine, 74, 13-33.
28. Thirukkumaran, C.M., Luider, J.M., Stewart, D.A., Cheng, T., Lupichuk, S.M., Nodwell, M.J., Russell, J.A., Auer, I.A. & Morris, D.G. (2003) Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood, 102, 377-387.
29. Van Riet, I. & Van Camp, B. (1993) The involvement of adhesion molecules in the biology of multiple myeloma. Leukemia & Lymphoma, 9, 441-452.
30. Wein, L.M., Wu, J.T. & Kirn, D.H. (2003) Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Research, 63, 1317-1324.
31. Wodarz, D. (2001) Viruses as antitumor weapons: defining conditions for tumor remission. Cancer Research, 61, 3501-3507.